General Medicine and Primary Care - Prova Education

17-32 of 141

Current Pharmacologic Approaches to Managing Pediatric Narcolepsy
Current Pharmacologic Approaches to Managing Pediatric Narcolepsy
MinuteCE®
Current Pharmacologic Approaches to Managing Pediatric Narcolepsy
Kiran Maski, MD, MPH
1.00 program credit
- Kiran Maski, MD, MPH
1.00 program credit
MinuteCE®
Pediatric Narcolepsy: How to Address Its Burden of Illness Through Prompt Recognition, Diagnosis, and Management
Kiran Maski, MD, MPH; Funke Afolabi-Brown, MD
1.00 credit 10 episodes
- Kiran Maski, MD, MPH
- Funke Afolabi-Brown, MD
- Anne M. Morse, DO
1.00 credit 10 episodes
Can We Talk? Optimizing Patient and Parent/Caregiver Buy-in to the Management of Pediatric Narcolepsy
Can We Talk? Optimizing Patient and Parent/Caregiver Buy-in to the Management of Pediatric Narcolepsy
MinuteCE®
Can We Talk? Optimizing Patient and Parent/Caregiver Buy-in to the Management of Pediatric Narcolepsy
Anne M. Morse, DO
1.00 program credit
- Anne M. Morse, DO
1.00 program credit
Pediatric Narcolepsy: Psychological and Social Comorbidities
Pediatric Narcolepsy: Psychological and Social Comorbidities
MinuteCE®
Pediatric Narcolepsy: Psychological and Social Comorbidities
Kiran Maski, MD, MPH
1.00 program credit
- Kiran Maski, MD, MPH
1.00 program credit
Evolving Therapy for Managing Pediatric Narcolepsy: Once-Nightly Sodium Oxybate
Evolving Therapy for Managing Pediatric Narcolepsy: Once-Nightly Sodium Oxybate
MinuteCE®
Evolving Therapy for Managing Pediatric Narcolepsy: Once-Nightly Sodium Oxybate
Anne M. Morse, DO
1.00 program credit
- Anne M. Morse, DO
1.00 program credit
Key Differences Among the Clinical Manifestations of Narcolepsy Symptoms in Children Versus Adults
Key Differences Among the Clinical Manifestations of Narcolepsy Symptoms in Children Versus Adults
MinuteCE®
Key Differences Among the Clinical Manifestations of Narcolepsy Symptoms in Children Versus Adults
Funke Afolabi-Brown, MD
1.00 program credit
- Funke Afolabi-Brown, MD
1.00 program credit
Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
CME/CE
Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
Scott Kahan, MD, MPH; Ken Fujioka, MD
0.50 credits
- Scott Kahan, MD, MPH
- Ken Fujioka, MD
- Carol Wysham
0.50 credits
Advances in Minimally Invasive Screening for Lung Cancer
Advances in Minimally Invasive Screening for Lung Cancer
CME/CE
Advances in Minimally Invasive Screening for Lung Cancer
Julie A. Barta, MD, ATSF; Peter J. Mazzone, MD, MPH, FCCP
0.25 credits
- Julie A. Barta, MD, ATSF
- Peter J. Mazzone, MD, MPH, FCCP
0.25 credits
What’s New About Gout? Nephrology Perspective
What’s New About Gout? Nephrology Perspective
MinuteCE®
What’s New About Gout? Nephrology Perspective
Abdul Abdellatif, MD, FASN; Richard Johnson, MD
- Abdul Abdellatif, MD, FASN
- Richard Johnson, MD
Can You Manage Patients With Uncontrolled Gout More Effectively?
Can You Manage Patients With Uncontrolled Gout More Effectively?
MinuteCE®
Can You Manage Patients With Uncontrolled Gout More Effectively?
Abdul Abdellatif, MD, FASN; John K. Botson, MD, RPh
- Abdul Abdellatif, MD, FASN
- John K. Botson, MD, RPh
MinuteCE®
The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
Richard Johnson, MD; Abdul Abdellatif, MD, FASN
- Richard Johnson, MD
- Abdul Abdellatif, MD, FASN
- John K. Botson, MD, RPh
- Brittany Weber, MD, PhD
Is Gout Hiding in the Nephrology Clinic?
Is Gout Hiding in the Nephrology Clinic?
MinuteCE®
Is Gout Hiding in the Nephrology Clinic?
Abdul Abdellatif, MD, FASN; Richard Johnson, MD
- Abdul Abdellatif, MD, FASN
- Richard Johnson, MD
Is Managing Gout in the Nephrology Clinic a Challenge?
Is Managing Gout in the Nephrology Clinic a Challenge?
MinuteCE®
Is Managing Gout in the Nephrology Clinic a Challenge?
Richard Johnson, MD; Abdul Abdellatif, MD, FASN
- Richard Johnson, MD
- Abdul Abdellatif, MD, FASN
Center of the Target: Which Patients Are Most Likely to Develop Gout?
Center of the Target: Which Patients Are Most Likely to Develop Gout?
MinuteCE®
Center of the Target: Which Patients Are Most Likely to Develop Gout?
Richard Johnson, MD; Abdul Abdellatif, MD, FASN
- Richard Johnson, MD
- Abdul Abdellatif, MD, FASN
What’s New About Gout? Rheumatology Perspective
What’s New About Gout? Rheumatology Perspective
MinuteCE®
What’s New About Gout? Rheumatology Perspective
Richard Johnson, MD; John K. Botson, MD, RPh
- Richard Johnson, MD
- John K. Botson, MD, RPh
Gout Beyond the Joints: What’s the Hidden Danger?
Gout Beyond the Joints: What’s the Hidden Danger?
MinuteCE®
Gout Beyond the Joints: What’s the Hidden Danger?
Richard Johnson, MD
- Richard Johnson, MD

2/7